(Q80147822)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Effects of the dopamine D3 receptor (DRD3) gene polymorphisms on risperidone response: a pharmacogenetic study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Jiekun Xuan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Xinzhi Zhao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Guang He

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Lan Yu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Lei Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Wei Tang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Xingwang Li

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Niufan Gu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Guoyin Feng

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Qinghe Xing

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Lin He

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

11 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

published in

Neuropsychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

305-311

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429404%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301418

29 December 2019

exact match

0 references

cites work

Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

REM sleep and cortisol responses to scopolamine during depression and remission in women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

The ser9gly SNP in the dopamine D3 receptor causes a shift from cAMP related to PGE2 related signal transduction mechanisms in transfected CHO cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Mutation and association analysis of the 5' region of the dopamine D3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Dopamine D3 receptor antagonists as therapeutic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Activation of human D3 dopamine receptor inhibits P/Q-type calcium channels and secretory activity in AtT-20 cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Dominant-negative mutants identify a role for GIRK channels in D3 dopamine receptor-mediated regulation of spontaneous secretory activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Dopamine D3 receptor Ser9Gly polymorphism and risperidone response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Survey on the pharmacodynamics of the new antipsychotic risperidone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

The role of serotonin in antipsychotic drug action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakistani patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Possible implications of the dopamine D(3) receptor in schizophrenia and in antipsychotic drug actions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

D3 dopamine receptor mRNA is widely expressed in the human brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Optimal dosing with risperidone: updated recommendations.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021

Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301418

7 January 2021